The Comparison of Diagnostic Yield Between Routine Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients Who at Risk of Colorectal Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patients at Risk of Colorectal Cancer
- Sponsor
- Hat Yai Medical Education Center
- Enrollment
- 241
- Locations
- 1
- Primary Endpoint
- Diagnostic yield in diagnosis colorectal tumor
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
Colonoscopy is the mainstay modality of choice in colorectal cancer screening worldwide. However, the rate of colonoscopy for colorectal cancer screening is very low (approximately 5-10%) because of the limited local medical resources (such as endoscopists and regional endoscope). This observational diagnostic test study aims to compare the diagnostic yield of routine computed tomography and colonoscopy in detecting colorectal tumors in patients at risk of colorectal cancer (aged more than 50 years and FIT+). The main question[s] it aims to answer are:
- To compare the diagnostic yield between the routine computed tomography and colonoscopy.
- To compare the procedure-related adverse events between the routine computed tomography and colonoscopy.
Detailed Description
All enrolled patients underwent routine CT scans of whole abdomen, then subsequently under went a colonoscopy on the next day
Investigators
Arunchai Chang
Head of Division of Gastroenterology, Department of Internal Medicine, Hatyai Hospital
Hat Yai Medical Education Center
Eligibility Criteria
Inclusion Criteria
- •Normal platelet count and normal result of PT, PTT
Exclusion Criteria
- •pregnancy or lactation
- •uncontrolled Diabetes Mellitus, hypertension, asthma, congestive heart failure
- •recent coronary artery disease within 3 months
- •eGFR lesser than 30 mL/min/1.73m2
- •hemophilia or uncontrolled or uncorrected coagulopathy
Outcomes
Primary Outcomes
Diagnostic yield in diagnosis colorectal tumor
Time Frame: 2 weeks
Sensitivity, specitivity, accuracy
Secondary Outcomes
- Procedure-related adverse events(2 weeks)